Market News Video
MNV MNV The 10 Most Popular Large-Caps in ETFs
Free Dividend Report - Top Ranked Stocks

Featured MNV Articles:

Commit To Buy Threshold Pharmaceuticals At $2.50, Earn 48.7% Annualized Using Options
Tuesday, October 20, 11:32 AM ET, by Market News Video Staff

Investors eyeing a purchase of Threshold Pharmaceuticals Inc (THLD) shares, but tentative about paying the ...

First Week of THLD January 2016 Options Trading
Tuesday, November 24, 11:24 AM ET, by Market News Video Staff

Investors in Threshold Pharmaceuticals Inc (THLD) saw new options begin trading this week, for the ...

Notable Monday Option Activity: MIC, THLD, WWE
Monday, December 7, 1:28 PM ET, by Market News Video Staff

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy ...

Short Interest Moves 50% Lower For THLD
Monday, December 28, 5:10 PM ET, by Market News Video Staff

The most recent short interest data has been released by the NASDAQ for the 12/15/2015 ...

Threshold Pharmaceuticals Inc Becomes Oversold (THLD)

By Market News Video Staff, Monday, November 5, 12:33 PM ET
Play Video: Learn About The RSI

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.

In trading on Monday, shares of Threshold Pharmaceuticals Inc (THLD) entered into oversold territory, hitting an RSI reading of 28.3, after changing hands as low as $4.17 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 39.5. A bullish investor could look at THLD's 28.3 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of THLD shares:

Threshold Pharmaceuticals Inc 1 Year Performance Chart

Looking at the chart above, THLD's low point in its 52 week range is $1.18 per share, with $9.28 as the 52 week high point that compares with a last trade of $4.24. Find out what 9 other oversold stocks you need to know about

Special Offer: Manage the risks of the markets better with a free 30 day trial to the Strategic Risk Management System.

Top Six Most Viewed Stories This Week @ Market News Video:

This Article's Word Cloud:   Buffett   Know   Looking   Management   Oversold   Relative   Special   Start   Strategic   THLD   Warren   analysis   below   better   bullish   changing   chart   comparison   entered   entry   falls   fearful   greedy   heavy   into   investor   know   level   look   markets   others   oversold   point   range   raquo   reading   selling   share   shares   sign   stock   technical   territory   that   trading   week   what   when   which   with
About Us - Advertise - Contact Us - Embedding Videos - Licensing Videos - Partners - mRSS / RSS Feed - Terms of Use - Privacy Policy - Video Widget
Home  |  Analyst News  Dividend Report  ETFs  Insider Report  Large Caps  Market Movers  Week Ahead Report  Weekly Market Wrap
MNV MNV Portfolio Channel Stock Market Definitions

Threshold Pharmaceuticals Inc Becomes Oversold (THLD) | Market News Video | Copyright © 2008 - 2017, All Rights Reserved

Any ideas and opinions presented in all Market News Video clips are for informational and educational purposes only, and do not reflect the opinions of BNK Invest, Inc. or any of its affiliates, subsidiaries or partners. In no way should any content contained herein be interpreted to represent trading or investment advice. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. Read Full Disclaimer.